FDA considers limiting authorization of certain monoclonal antibody treatments

FDA Push to Restrict Ron DeSantis’ Favorite Monoclonal Antibody COVID Treatment

The FDA wants to restrict monoclonal antibody treatment, citing dodgy science. Florida’s governor Ron DeSantis has pushed the treatment over vaccines.

COVID Omicron News: FDA considers limiting authorization of certain monoclonal antibody treatments

The agency points to the growing body of evidence that shows some monoclonal therapies don't effectively neutralize the virus' omicron variant, according to a source.

FDA considers limiting authorization of certain monoclonal antibody treatments

(CNN) -- Federal regulators are considering limiting the authorization of certain monoclonal antibody treatments that have not proved effective against the omicron variant of the coronavirus, a source familiar with the decision-making told CNN. The U.S. Food and Drug Administration could decide in the coming

FDA considers limiting authorization of certain monoclonal antibody treatments

By Steve Contorno, CNNFederal regulators are considering limiting the authorization of certain monoclonal antibody treatments that have not proved effective against the Omicron variant of the coronavirus, a source familiar with the decision-making told CNN.The US Food and Drug Administration could decide in the coming days to take steps to curb the use of antibody treatments produced by Eli Lilly and Regeneron, the source said, pointing to the g…

FDA considers limiting authorization of certain monoclonal antibody treatments

By Steve Contorno, CNNFederal regulators are considering limiting the authorization of certain monoclonal antibody treatments that have not proved effective against the Omicron variant of the coronavirus, a source familiar with the decision-making told CNN.The US Food and Drug Administration could decide in the coming days to take steps to curb the use of antibody treatments produced by Eli Lilly and Regeneron, the source said, pointing to the g…

FDA considers limiting authorization of certain monoclonal antibody treatments

Federal regulators are considering limiting the authorization of certain monoclonal antibody treatments that have not proved effective against the Omicron variant of the coronavirus, a source familiar with the decision-making told CNN.